2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SJR(2022): 0.78
Open Access

Health Promot Perspect. 2023;13(1): 40-46. doi: 10.34172/hpp.2023.05
PMID: 37309432        PMCID: PMC10257564


Access to medicines through global health diplomacy

Vijay Kumar Chattu 1,2,3 * ORCID, Bawa Singh 4 ORCID, Sanjay Pattanshetty 5 ORCID, Srikanth Reddy 6,7 ORCID

Cited by CrossRef: 0

1- Ashiwaju B, Orikpete O, Alade E, Raji A, Adesanya A, Nwankwo T. Impact of Drug Price Regulation on Patient Access to Medicines: A Systematic Review. 2023;7(4):112 [Crossref]
2- Bayked E, Assfaw A, Toleha H, Zewdie S, Biset G, Ibirongbe D, Kahissay M. Willingness to pay for National Health Insurance Services and Associated Factors in Africa and Asia: a systematic review and meta-analysis. Front Public Health. 2024;12 [Crossref]
3- Yadav S, Rawal G, Jeyaraman M. India’s Decision to Deny an Extension of Patent for Bedaquiline: A Public Health Imperative. 2023; [Crossref]

Indexing and Abstracting

2-year Impact Factor: 4.4


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  

Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission